trastuzumab

trastuzumab   Dan trastuzumab

The story of trastuzumab begins with Axel Ullrich's dedication to the concept that receptor tyrosine kinases must be the key to many human

Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab

รวิศ หาญอุตสาหะ Subcutaneous trastuzumab has a similar safety profile to intravenous trastuzumab and is non-inferior in terms of pharmacokinetic profile and efficacy and If you're having trastuzumab to treat primary breast cancer after surgery, it's usually given for 1 year Some people may be offered